Stories

OHSU encabeza una iniciativa para que los ensayos sobre cáncer sean más inclusivos

By Chris Lydgate March 02, 2023

Equipo de Oregon Health & Science University trabaja para que los beneficios de los ensayos clínicos lleguen a personas de comunidades con poco acceso a servicios.

OHSU leading effort to make cancer trials more inclusive

By Chris Lydgate March 02, 2023

Team at Oregon Health & Science University working to bring benefits of clinical trials to people in underserved communities.

Investigadores de OHSU identifican un promisorio tratamiento de última generación contra el cáncer

By Joe Rojas-Burke February 10, 2023

El descubrimiento de un químico apunta a la creación de inhibidores de PARP-1 de última generación, un objetivo crítico en cánceres de ovario, mama y próstata.

OHSU researchers identify promising next-generation cancer treatment

By Joe Rojas-Burke February 10, 2023

Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.

Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer

By Nicole Rideout January 17, 2023

Treatment with sodium thiosulfate will improve health outcomes and quality of life for pediatric cancer patients.

OHSU Knight Cancer Institute tapped for participation in a national consortium to accelerate cancer drug discovery

By Amanda Gibbs December 20, 2022

As the only center in the Pacific Northwest, OHSU will collaborate with other selected centers to address unmet needs in cancer therapy.

University of Oregon football helmet auction raises more than $66,000 for breast cancer research at OHSU

By Amanda Gibbs October 26, 2022

OHSU Knight Cancer Institute director, employees share their appreciation in a thank-you video.

OHSU center for pancreatic care receives $10 million gift to ‘save lives of pancreatic cancer patients and help their families’

By Amanda Gibbs March 11, 2022

Funding will support therapeutic advances, increase services for high-risk patients, fuel expansion in early cancer detection.

Breast cancer screening: Study shows rate of overdiagnosis not as high as previously reported

By Amanda Gibbs March 07, 2022

New study co-led by OHSU researchers provides most robust U.S. estimate to date, shows overdiagnosis not as ‘alarmingly frequent’ as commonly believed.

OHSU Knight Cancer Institute applauds updated Biden administration ‘Cancer Moonshot’ initiative

By Amanda Gibbs February 02, 2022

Institute leaders helped shape revamped plans, say OHSU will be ‘instrumental’ in contributing to the cause moving forward.

Stories

OHSU in the News